News articles

News article list

• Avelumab not recommended as a maintenance treatment of urothelial cancer

  NICE has issued draft guidance which does not recommend avelumab for maintenance treatment of urothelial cancer after platinum-based chemotherapy.

• More people with rare genetic disorder eligible for nusinersen

  Following a review of data collected as part of the Managed Access Agreement, more people with spinal muscular atrophy (SMA) are to benefit from nusinersen.

• New guidance aims to achieve fairer outcomes for looked-after children and young people

  Looked after children and young people should be considered ‘one of their own’ by carers, to help them to reach their full potential, new NICE draft guidelines say.

• NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation

  NICE has today (27 April 2021) published its updated guideline on the diagnosis and management of atrial fibrillation (AF).

• NICE recommends new treatment for rare blood disorder

  Hundreds of people with a rare blood disorder have access to a new treatment regimen following draft guidance from NICE.

• NICE signs up to join the GetReal Institute

  NICE and the GetReal Institute: facilitating the adoption and implementation of real-world evidence in health care decision-making.